Cambridge Investment Research Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 6,215 shares of JAZZ stock, worth $740,082. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,215
Previous 6,026
3.14%
Holding current value
$740,082
Previous $643,000
7.62%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding JAZZ
# of Institutions
501Shares Held
57.8MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$753 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$732 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$295 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$240 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$240 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.46B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...